330 related articles for article (PubMed ID: 29923062)
21. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
[TBL] [Abstract][Full Text] [Related]
22. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
[TBL] [Abstract][Full Text] [Related]
23. Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis.
Albaramki J; Dmour H; Shboul M; Bonnard C; Venkatesh B; Odeh R
Turk J Pediatr; 2019; 61(1):130-133. PubMed ID: 31559735
[TBL] [Abstract][Full Text] [Related]
24. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
Finer G; Price HE; Shore RM; White KE; Langman CB
Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
[TBL] [Abstract][Full Text] [Related]
25. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Regulation of mineral metabolism and mineralization by FGF23].
Fukumoto S
Clin Calcium; 2015 May; 25(5):687-91. PubMed ID: 25926572
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Simple Diagnostic Method to Detect Gain and Loss of Function Defects in Fibroblast Growth Factor-23.
Ramadan AR; Shawar SM; Alghamdi MA
Horm Res Paediatr; 2016; 86(1):45-52. PubMed ID: 27355663
[TBL] [Abstract][Full Text] [Related]
27. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.
Ichikawa S; Baujat G; Seyahi A; Garoufali AG; Imel EA; Padgett LR; Austin AM; Sorenson AH; Pejin Z; Topouchian V; Quartier P; Cormier-Daire V; Dechaux M; Malandrinou FCh; Singhellakis PN; Le Merrer M; Econs MJ
Am J Med Genet A; 2010 Apr; 152A(4):896-903. PubMed ID: 20358599
[TBL] [Abstract][Full Text] [Related]
28. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).
Farrow EG; Imel EA; White KE
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):735-47. PubMed ID: 22142751
[TBL] [Abstract][Full Text] [Related]
29. Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis.
Sheppard AJ; Theng EH; Paravastu SS; Wojnowski NM; Farhadi F; Morris MA; Hartley IR; Gafni RI; Roszko KL; Collins MT; Saboury B
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1432-1446. PubMed ID: 38660800
[TBL] [Abstract][Full Text] [Related]
30. [FGF23 and skeletal metabolism].
Michigami T
Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
[TBL] [Abstract][Full Text] [Related]
31. GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis.
Demellawy DE; Chang N; de Nanassy J; Nasr A
Scand J Rheumatol; 2015; 44(2):170-2. PubMed ID: 25351881
[No Abstract] [Full Text] [Related]
32. Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect.
Pallone SG; Kunii IS; da Silva REC; Lazaretti-Castro M
Calcif Tissue Int; 2022 Jul; 111(1):102-106. PubMed ID: 35338393
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.
Araya K; Fukumoto S; Backenroth R; Takeuchi Y; Nakayama K; Ito N; Yoshii N; Yamazaki Y; Yamashita T; Silver J; Igarashi T; Fujita T
J Clin Endocrinol Metab; 2005 Oct; 90(10):5523-7. PubMed ID: 16030159
[TBL] [Abstract][Full Text] [Related]
34. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
[TBL] [Abstract][Full Text] [Related]
35. Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease.
Guerra MG; Videira T; de Fonseca D; Vieira R; Dos Santos J; Pinto S
Scand J Rheumatol; 2020 Jan; 49(1):80-81. PubMed ID: 31213107
[No Abstract] [Full Text] [Related]
36. PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34.
Ovejero D; Hartley IR; de Castro Diaz LF; Theng E; Li X; Gafni RI; Collins MT
J Bone Miner Res; 2022 Feb; 37(2):179-184. PubMed ID: 34464000
[TBL] [Abstract][Full Text] [Related]
37. A Cross-Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis.
Lee AE; Chu EY; Gardner PJ; Duverger O; Saikali A; Wang SK; Gafni RI; Hartley IR; Ten Hagen KG; Somerman MJ; Collins MT
JBMR Plus; 2021 May; 5(5):e10470. PubMed ID: 33977199
[TBL] [Abstract][Full Text] [Related]
38. A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.
Esapa CT; Head RA; Jeyabalan J; Evans H; Hough TA; Cheeseman MT; McNally EG; Carr AJ; Thomas GP; Brown MA; Croucher PI; Brown SD; Cox RD; Thakker RV
PLoS One; 2012; 7(8):e43205. PubMed ID: 22912827
[TBL] [Abstract][Full Text] [Related]
39. Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.
Peluso G; Tian E; Abusleme L; Munemasa T; Mukaibo T; Ten Hagen KG
J Biol Chem; 2020 Jan; 295(5):1411-1425. PubMed ID: 31882545
[TBL] [Abstract][Full Text] [Related]
40. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.
Sprecher E
J Invest Dermatol; 2010 Mar; 130(3):652-60. PubMed ID: 19865099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
